The Genetically Encoded Small Illuminant (GESI) technology proposed here consists of using an one-bead- one-compound (OBOC) combinatorial library screen to identify short peptide(s) that activate fluorophores/dyes, which can be coupled to alterations of their chemical environment including conformational change upon ligand binding and phosphorylation of the peptide. These peptides can then be genetically fused to a target protein to enable functional cellular imaging in vitro and in vivo. As proof of concept, we will fuse the identified peptide to integrin and use the exogenously added GESI-peptide-activating dye to demonstrate the utility of the proposed genetically encoded functional imaging system in living cells. We will test their ability to measure spatiotemporal dynamics, interactions with ligands and phosphorylation of intracellular domain. Integration of these distinct GESIs into one integrin protein will allow concurrent probing of multiple integrin functions in real time in living cell. Impact: GESI peptides can specifically bind to and activate the fluorescence of selected organic dyes. Some GESI peptides will do so only after binding to Ca2+, conformational changes or post-translationally modified, such as phosphorylation. Therefore, when transfected into a living cell, they can illuminate the spatiotemporal regulation and modification of proteins of interest. Like GFP, GESI can also be expressed in transgenic animal, or in tumor cells implanted into nude mice as xenograft. If the dye can be delivered to the tissue of interest, GESI reporting can occur in living animals as well. The genetic illuminants are small (1200- 1900 daltons), thus can be readily inserted along the sequence of the native proteins without interfering with their physiological functions. We can create functional peptide-dye pairs without overlapping spectrum to simultaneously monitor a number of PTMs or other cellular functions concurrently, to reveal system level regulation in living cells. This research will expand the catalogue of fluorescence imaging tools; their versatility will be broadly applicable to many fields of biology, including cancer.
Specific aims of this proposed project are:
Aim 1. Design and synthesis of a series of organic dyes suitable for GESI development.
Aim 2. Multiplex tracking of protein dynamics and ligand-receptor interactions with GESIs using integrin as a model system.
Aim 3. GESIs for post-translational modification of intracellular domain of integrin.

Public Health Relevance

GESI: a novel technology for functional imaging in living cells Narrative: The proposed work builds on preliminary data that show the feasibility of designing, screening for, identifying, isolating, analyzing, and testing in vitro peptides that activate fluorescence of a single dye malachite green (MG). Here we expand on these studies by increasing the number of dyes to be screened against (including synthesizing new dyes; Aim 1) and developing and screening OBOC peptide libraries enable imaging of target protein localization and receptor- ligand interactions (Aim 2); and post translational modifications (Aim 3). As proof of concept, we will fuse the identified peptides/dye partners to integrin and test their ability to measure spatiotemporal dynamics, activation and phosphorylation. Integration of these distinct GESIs into one integrin protein will allow concurrent probing of multiple integrin functions in real time in living cell.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Exploratory/Developmental Grants Phase II (R33)
Project #
5R33CA196445-03
Application #
9532104
Study Section
Special Emphasis Panel (ZCA1)
Program Officer
Knowlton, John R
Project Start
2016-08-15
Project End
2019-07-31
Budget Start
2018-08-01
Budget End
2019-07-31
Support Year
3
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of California Davis
Department
Biochemistry
Type
Schools of Medicine
DUNS #
047120084
City
Davis
State
CA
Country
United States
Zip Code
95618
Fujita, Masaaki; Davari, Parastoo; Takada, Yoko K et al. (2018) Stromal cell-derived factor-1 (CXCL12) activates integrins by direct binding to an allosteric ligand-binding site (site 2) of integrins without CXCR4. Biochem J 475:723-732
Arun, Adith S; Tepper, Clifford G; Lam, Kit S (2018) Identification of integrin drug targets for 17 solid tumor types. Oncotarget 9:30146-30162
Yu, Jessica; Lee, Chia-Ying; Changou, Chun Austin et al. (2017) The CD9, CD81, and CD151 EC2 domains bind to the classical RGD-binding site of integrin ?v?3. Biochem J 474:589-596
Takada, Yoshikazu; Takada, Yoko K; Fujita, Masaaki (2017) Crosstalk between insulin-like growth factor (IGF) receptor and integrins through direct integrin binding to IGF1. Cytokine Growth Factor Rev 34:67-72
Tang, Yuchen; Thillier, Yann; Liu, Ruiwu et al. (2017) Single-Bead Quantification of Peptide Loading Distribution for One-Bead One-Compound Library Synthesis Using Confocal Raman Spectroscopy. Anal Chem 89:7000-7008
Takada, Yoko K; Yu, Jessica; Fujita, Masaaki et al. (2017) Direct binding to integrins and loss of disulfide linkage in interleukin-1? (IL-1?) are involved in the agonistic action of IL-1?. J Biol Chem 292:20067-20075
Liu, Ruiwu; Li, Xiaocen; Lam, Kit S (2017) Combinatorial chemistry in drug discovery. Curr Opin Chem Biol 38:117-126
Cedano Prieto, Dora Maria; Cheng, Yushen; Chang, Chih-Chieh et al. (2017) Direct integrin binding to insulin-like growth factor-2 through the C-domain is required for insulin-like growth factor receptor type 1 (IGF1R) signaling. PLoS One 12:e0184285